NEW YORK, NY & KING OF PRUSSIA, PA — Datavant and United BioSource Corporation (UBC) have entered into a strategic collaboration aimed at reshaping how pharmaceutical companies generate real-world evidence and support patients in specialty therapies. The partnership combines Datavant’s large-scale data connectivity and privacy infrastructure with UBC’s expertise in late-phase research and patient access programs.
The companies will roll out two initial offerings: Modern Observational Research Study Designs and Enhanced Patient Access Programs. Both are intended to give life sciences organizations faster, richer and more actionable insights by linking operational capabilities with real-world data sources.
Arnaub Chatterjee, Datavant’s general manager and president of life sciences, said the collaboration closes long-standing gaps between evidence generation and study execution. He noted that the partnership aims to accelerate research timelines while improving the safety and quality of therapies available to patients.
Datavant’s network enables privacy-preserving linkage across data from more than 350 healthcare organizations, including access to both structured and unstructured electronic medical records through its provider ecosystem. UBC contributes deep experience in registries, epidemiology and patient access services.
The joint offerings are designed to help pharmaceutical teams make more precise decisions in late-phase development and commercialization. Modern Observational Research Study Designs leverage real-world data to support decentralized and direct-to-patient models, which can broaden recruitment, reduce costs and produce more comprehensive evidence on patient journeys. Enhanced Patient Access Programs integrate data on adherence, affordability and prescribing with secondary sources to identify access challenges, measure program value and improve patient outcomes.
UBC’s senior vice president of strategy, partnerships and innovation, Brett Huselton, said the collaboration reflects growing demand for more connected and efficient approaches to research and support services. He added that both companies are aligned on building solutions that prioritize patient outcomes while meeting the industry’s evolving data and compliance needs.
The partnership represents the first phase of a broader initiative to integrate Datavant’s data infrastructure with UBC’s service capabilities, positioning the two firms to deliver scalable, privacy-centric tools for the biopharmaceutical sector.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.